Recursion Pharmaceuticals, Inc. (RXRX)

Healthcare · Biotechnology · NASDAQ

Recursion Pharmaceuticals, Inc. (RXRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.17B and a free-cash-flow yield of -21.0%. Over the most recent reported fiscal year, revenue grew 27.0%.

Market cap	$2.17B
Trailing P/E	—
FCF yield	-21.0%
Revenue growth (YoY)	+27.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RXRX data on Nama Insights →